We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Cambrex completed an investment project at its facility in Tallinn, Estonia to upgrade its kilogram-scale lab for the manufacture of pharmaceutical intermediates under current good manufacturing practice (CGMP) conditions.
On the day the state of emergency was declared in Estonia, a public-private e-hackathon was held as one of the first crisis responses to offer quick and feasible solutions to combat the impacts of COVID-19 outbreak.